5092 Domain in virus attachment proteins
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 5 | 5.1 | 0.98× | q = 1.00 | |
| Homogeneous metal compounds | 9 | 11.6 | 0.78× | q = 0.39 | |
| Nucleosides, nucleotides, and analogues | 0 | 6.5 | 0 | q = 2.0e-3 | |
| Organic nitrogen compounds | 2 | 0.8 | 2.65× | not tested | |
| Organic oxygen compounds | 10 | 4.7 | 2.12× | not tested | |
| Organosulfur compounds | 1 | 0.5 | 2.05× | not tested | |
| Organic acids and derivatives | 4 | 3.7 | 1.09× | not tested | |
| Organoheterocyclic compounds | 1 | 3.6 | 0.28× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 33 |
| DB04265 | SLB | N-acetyl-beta-neuraminic acid | 32 |
| DB08357 | P4G | Diethylene glycol diethyl ether | 11 |
| DB00130 | GLN | L-Glutamine | 6 |
| DB00142 | GLU | Glutamic acid | 4 |
| DB00160 | ALA | Alanine | 3 |
| DB01822 | DTD | (4R,5R)-1,2-dithiane-4,5-diol | 2 |
| DB04237 | TAM | Tris(Hydroxyethyl)Aminomethane | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 52 |
| SIA | N-acetyl-alpha-neuraminic acid | 31 |
| SLB | N-acetyl-beta-neuraminic acid | 31 |
| BR | BROMIDE ION | 15 |
| MGmetal | MAGNESIUM ION | 15 |
| CL | CHLORIDE ION | 12 |
| P4G | 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE | 11 |
| 18D | 3,5-dideoxy-5-(propanoylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 9 |
| NAmetal | SODIUM ION | 9 |
| ANA | methyl 4-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid | 6 |
| GLN | GLUTAMINE | 6 |
| CAmetal | CALCIUM ION | 5 |
| 423 | (1-{2-[bis(2-{4-[({(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)methyl]-1H-1,2,3-triazol-1-yl}ethyl)amino]ethyl}-1H-1,2,3-triazol-4-yl)methyl (6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranosidonic acid | 3 |
| 425 | 2-(1-{2-[bis(2-{4-[2-({(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)ethyl]-1H-1,2,3-triazol-1-yl}ethyl)amino]ethyl}-1H-1,2,3-triazol-4-yl)ethyl (6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranosidonic acid | 3 |
| 42D | 3,5-dideoxy-5-[(methoxycarbonyl)amino]-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 3 |
| GLU | GLUTAMIC ACID | 3 |
| MNA | 2-O-methyl-5-N-acetyl-alpha-D-neuraminic acid | 3 |
| PKM | 4-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 3 |
| SIO | methyl 4,9-di-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid | 3 |
| DTD | DITHIANE DIOL | 2 |